Detection of von Willebrand factor-cleaving protease (ADAMTS-13) in human platelets

Biochemical and Biophysical Research Communications

Volumn 313, Issue 1, 2004, Pages 212-216

  Suzuki, Misako ^a   Murata, Mitsuru ^a   Matsubara, Yumiko ^a   Uchida, Toshihiro ^b   Ishihara, Hiroaki ^b   Shibano, Toshiro ^b   Ashida, Shin Ichiro ^b   Soejima, Kenji ^c   Okada, Yasunori ^a   Ikeda, Yasuo ^a  

^a KEIO UNIVERSITY   (Japan)

^b DAIICHI SANKYO CO   (Japan)

^c Chemo Sero Therapeutic Research Institute   (Japan)

Author keywords

ADAMTS 13; Expression; Platelets; Real time PCR; Thrombosis; TTP; vWF; vWF CP

Indexed keywords

MESSENGER RNA; VON WILLEBRAND FACTOR; VON WILLEBRAND FACTOR CLEAVING PROTEINASE;

ARTICLE; BLOOD VESSEL INJURY; CELL FUNCTION; CELL MEMBRANE PERMEABILITY; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME STRUCTURE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; NORMAL HUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; QUANTITATIVE ANALYSIS; THROMBOCYTE; THROMBOGENESIS; WESTERN BLOTTING;

THROMBUS;

EID: 10744220711     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbrc.2003.11.111     Document Type: Article

References (12)

1. Furlan M., Robles R., Lammle B. Partial purification and characterization of a protease from human plasma cleaving von Willebrand factor to fragments produced by in vivo proteolysis. Blood. 87:1996;4223-4234.
2. Tsai H.M. Physiologic cleavage of von Willebrand factor by a plasma protease is dependent on its conformation and requires calcium ion. Blood. 87:1996;4235-4244.
3. Tsai H.M., Lian E.C.Y. Antibodies to von Willebrand factor-cleaving protease in acute thrombotic thrombocytopenic purpura. N. Engl. J. Med. 339:1998;1585-1594.
4. Furlan M., Robles R., Galbusera M., Remuzzi G., Kyrle P.A., Brenner B., Krause M., Scharrer I., Aumann V., Mittler U., Solenthaler M., Lammle B. Von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome. N. Engl. J. Med. 339:1998;1578-1584.
5. Furlan M., Robles R., Solenthaler M., Wassmer M., Sandoz P., Lammle B. Deficient activity of von Willebrand factor-cleaving protease in chronic relapsing thrombotic thrombocytopenic purpura. Blood. 89:1997;3097-3103.
6. Zheng X., Chung D., Takayama T.K., Majerus E.M., Sadler J.E., Fujikawa K. Structure of von Willebrand factor-cleaving protease (ADAMTS13), a metalloprotease involved in thrombotic thrombocytopenic purpura. J. Biol. Chem. 276:2001;41059-41063.
7. Fujikawa K., Suzuki H., McMullen B., Chung D. Purification of human von Willebrand factor-cleaving protease and its identification as a new member of the metalloproteinase family. Blood. 98:2001;1662-1666.
8. Levy G.G., Nichols W.C., Lian E.C., Foroud T., McClintick J.N., McGee B.M., Yang A.Y., Siemieniak D.R., Stark K.R., Gruppo R., Sarode R., Shurin S.B., Chandrasekaran V., Stabler S.P., Sabio H., Bouhassira E.E., Upshaw J.D. Jr., Ginsburg D., Tsai H.M. Mutations in a member of the ADAMTS gene family cause thrombotic thrombocytopenic purpura. Nature. 413:2001;488-494.
9. Soejima K., Mimura N., Hirashima M., Maeda H., Hamamoto T., Nakagaki T., Nozaki C. A novel human metalloprotease synthesized in the liver and secreted into the blood: possibly, the von Willebrand factor-cleaving protease? J. Biochem. (Tokyo). 130:2001;475-480.
10. Plaimauer B., Zimmermann K., Volkel D., Antoine G., Kerschbaumer R., Jenab P., Furlan M., Gerritsen H., Lammle B., Schwartz H.P., Scheiflinger F. Cloning, expression, and functional characterization of the von Willebrand factor-cleaving protease (ADAMTS13). Blood. 100:2002;3626-3632.
11. 747 → Pro) causing thrombasthenic phenotypes in four Japanese patients Br. J. Haematol. 102:1998;829-840.
12. Kornmann M., Danenberg K.D., Arber N., Beger H.G., Danenberg P.V., Kore M. Inhibition of cyclin D1 expression in human pancreatic cancer cells is associated with increased chemosensitivity and decreased expression of multiple chemoresistance genes. Cancer Res. 59:1999;3505-3511.